Application of compound VS1 in preparation of anti-non-small cell lung cancer medicine
A non-small cell lung cancer, compound technology, applied in the field of known compounds, can solve problems such as difficult to develop lung cancer therapies or drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] This example verifies the inhibitory effect of compound VS1 of the present invention on non-small cell lung cancer cell lines:
[0030] (1) A549 and MRC-5 adherent cells in the logarithmic growth phase were selected, digested with trypsin, and formulated with DMEM and improved α-MEM medium containing 10% fetal bovine serum to prepare 5×10 4 cells / ml of cell suspension, inoculated in 96-well culture plate, inoculated 200 μl per well, 37°C, 5% CO 2 to cultivate.
[0031] (2) Configure the drug sample mother solution (compound VS1 of the present invention), incubate and shake the drug sample to dissolve with 50% DMSO solution, and configure a solution with a final concentration of 2 mg / ml; and configure a five-fold diluted working solution , the final concentration is 1mg / ml, 200μg / ml, 40μg / ml, 8μg / ml, 160ng / ml, 32ng / ml.
[0032] Prepare positive drug nimustine (a known anti-non-small cell lung cancer drug) 50mg / ml mother solution, and prepare five-fold diluted working s...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com